Travel-Associated Health Risks for Patients With Inflammatory Bowel Disease

Ben‐Horin, Shomron; Bujanover, Yoram; Goldstein, Sergey; Nadler, Moshe; Lang, Alon; Kopylov, Uri; Katz, Lior H.; Lahat, Adi; Schwartz, Eli; Avidan, Benjamin

doi:10.1016/j.cgh.2011.10.025

Cited by 22 publications

(15 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, our findings may represent immunocompromised persons who were well and confident enough to travel. This data is supported by two different recent studies 7 8. A study by Ben-Horin et al showed that IM medications in IBD are not associated with any risk of travel-related illness 7.…”

Section: Discussionsupporting

confidence: 63%

“…This data is supported by two different recent studies 7 8. A study by Ben-Horin et al showed that IM medications in IBD are not associated with any risk of travel-related illness 7. Baaten et al 8 demonstrated that with the exception of travel-related skin infections, patients with IBD receiving IM medications do not have symptomatic infectious diseases more often or longer than non-immunocompromised travellers 8…”

Section: Discussionmentioning

confidence: 71%

“…Were these episodes of self-limiting diarrhoea minimal disease flare-ups? It has been suggested7 that most illnesses in developed countries are the result of disease flares and not enteric infections. However, one of the healthy travellers (control) also reported diarrhoeal symptoms while travelling with a patient who had IBD.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Diarrhoeal episodes in travellers suffering from IBD

Ellul

Fenech

Azzopardi

et al. 2012

Frontline Gastroenterol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 63%

Section: Discussionmentioning

confidence: 71%

See 1 more Smart Citation

Diarrhoeal episodes in travellers suffering from IBD

Ellul

Fenech

Azzopardi

et al. 2012

Frontline Gastroenterol

View full text Add to dashboard Cite

show abstract

“…58 No increase risk for traveler's diarrhea has been reported for IBD patients. 90,91 Nonetheless, because it might act as a trigger for IBD flares, a more careful approach in its prophylaxis and treatment may be appropriate in IBD patients (especially in the immunocompromised ones). The European Crohn's and Colitis Organisation recommends to IBD patients travelling to developing countries to carry fluorquinolones as for empirical self-treatment of traveler's diarrhea.…”

Section: Treatment Of Intestinal Infections In Patients With Known Ibdmentioning

confidence: 98%

Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile

Lobatón

Domènech

2016

Inflammatory Bowel Diseases

View full text Add to dashboard Cite

Besides genetics and environmental factors, intestinal microbiota seem to play a major role in the pathogenesis of inflammatory bowel diseases. For many decades, it has been said that some enteropathogens may even trigger both inflammatory bowel disease development and disease flares. For this reason, stool testing had been performed in inflammatory bowel disease flares but current guidelines only recommend to rule out Clostridium difficile infection and there is no clear advice for other enteropathogens given that the scarce available evidence points at a low prevalence of this sort of intestinal superinfections with no clear impact on disease course. The present article reviews the current knowledge about the role of bacterial enteropathogens on disease pathogenesis and flares beyond C. difficile.

show abstract

“…Inflammatory bowel disease (IBD) and foreign travel is associated with an increased risk of travel-related morbidity caused through exacerbations of IBD, acquisition of infectious diseases endemic to the destination and availability of healthcare and medicines while abroad 1 2. Patients receiving immunosuppressive medication have an increased susceptibility to these infections in addition to an attenuated immune response to vaccinations 1 3–6.…”

Section: Introductionmentioning

confidence: 99%

Travel health and pretravel preparation in the patient with inflammatory bowel disease

Greveson

Shepherd

Mulligan

et al. 2015

Frontline Gastroenterol

View full text Add to dashboard Cite

Background and aimsForeign travel for people with inflammatory bowel disease (IBD) carries an increased risk of travel-related morbidity. There is limited research looking specifically at travel-associated health risks and travel preparation in patients with IBD. The aims of this study are to explore the experience of travel, pretravel preparation undertaken by the patient with IBD and examine IBD healthcare professionals’ (HCP) confidence at providing travel advice and the content of that advice.MethodsA survey of patients with IBD attending an outpatient clinic with a separate online survey sent to IBD HCPs recruited using regional and international network databases.ResultsA total of 132 patients with IBD, Crohn's disease (67/132, 51%), male (60/132, 45%) and 128 HCPs (IBD nurse specialist 113, 88%; IBD physician 15, 12%) completed the questionnaires. IBD affected travel to some extent in 62% (82/132) of patients, and 64% (84/132) had experienced an IBD flare, of whom 64% still travelled overseas during this time. Only 23% (31/132) travellers sought pretravel medical advice and 40% (53/132) obtained travel insurance. Forty-eight per cent of respondents on immunomodulator therapy were unaware of the need to avoid live vaccines. Twenty-seven per cent (34/128) of IBD HCPs are not confident at providing pretravel advice; vaccination advice (54%), obtaining travel insurance (61%) and healthcare abroad (78%) are the areas of most uncertainty.ConclusionsPatients do not seek adequate pretravel advice and consultations for those who do are often deficient. The majority of IBD professionals are not confident to provide comprehensive travel advice. Greater IBD-specific travel education and awareness is needed for both patients with IBD and professionals.

show abstract

Travel-Associated Health Risks for Patients With Inflammatory Bowel Disease

Cited by 22 publications

References 9 publications

Diarrhoeal episodes in travellers suffering from IBD

Diarrhoeal episodes in travellers suffering from IBD

Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile

Travel health and pretravel preparation in the patient with inflammatory bowel disease

Contact Info

Product

Resources

About